Viewing Study NCT04858256


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-01-06 @ 8:37 PM
Study NCT ID: NCT04858256
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2021-04-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module